144 related articles for article (PubMed ID: 37026172)
1. Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone as Adjunctive Therapy in Septic Shock: A Retrospective Cohort Study.
Lock AE; Gutierrez GC; Hand EO; Barthol CA; Attridge RL
Ann Pharmacother; 2023 Dec; 57(12):1375-1388. PubMed ID: 37026172
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children.
Hebbar KB; Stockwell JA; Fortenberry JD
Intensive Care Med; 2011 Mar; 37(3):518-24. PubMed ID: 21152900
[TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.
Heming N; Renault A; Kuperminc E; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Leone M; Timsit JF; Misset B; Benali MA; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Bounab R; Maxime V; Moine P; Bellissant E; Annane D; ;
Lancet Respir Med; 2024 May; 12(5):366-374. PubMed ID: 38310918
[TBL] [Abstract][Full Text] [Related]
4. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
Annane D; Renault A; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Martin C; Timsit JF; Misset B; Ali Benali M; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Amathieu R; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Maxime V; Bellissant E;
N Engl J Med; 2018 Mar; 378(9):809-818. PubMed ID: 29490185
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
; Annane D; Cariou A; Maxime V; Azoulay E; D'honneur G; Timsit JF; Cohen Y; Wolf M; Fartoukh M; Adrie C; Santré C; Bollaert PE; Mathonet A; Amathieu R; Tabah A; Clec'h C; Mayaux J; Lejeune J; Chevret S
JAMA; 2010 Jan; 303(4):341-8. PubMed ID: 20103758
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Early Versus Late Initiation of Hydrocortisone in Patients With Septic Shock in the ICU Setting.
Ragoonanan D; Allen B; Cannon C; Rottman-Pietrzak K; Bello A
Ann Pharmacother; 2022 Mar; 56(3):264-270. PubMed ID: 34109850
[TBL] [Abstract][Full Text] [Related]
7. Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.
Oh M; Patanwala AE; Alkhatib N; Almutairi A; Abraham I; Erstad B
Crit Care Med; 2020 Oct; 48(10):e906-e911. PubMed ID: 32701552
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Early Versus Late Adjunctive Vasopressin and Corticosteroids in Patients With Septic Shock.
Alshehri AM; Kovacevic MP; Dube KM; Lupi KE; DeGrado JR
Ann Pharmacother; 2024 May; 58(5):461-468. PubMed ID: 37542417
[TBL] [Abstract][Full Text] [Related]
9. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
Annane D; Sébille V; Charpentier C; Bollaert PE; François B; Korach JM; Capellier G; Cohen Y; Azoulay E; Troché G; Chaumet-Riffaud P; Bellissant E
JAMA; 2002 Aug; 288(7):862-71. PubMed ID: 12186604
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the effectiveness and safety of hydrocortisone therapy in cancer patients with septic shock.
Nazer L; AlNajjar T; Al-Shaer M; Rimawi D; Hawari F
J Oncol Pharm Pract; 2015 Aug; 21(4):274-9. PubMed ID: 24781452
[TBL] [Abstract][Full Text] [Related]
11. Association of mortality with fludrocortisone addition to hydrocortisone treatment among septic shock patients: a propensity score matching analysis.
Cheng X; Fu Z; Liu Y; Zheng X; Hu T
Front Med (Lausanne); 2023; 10():1190758. PubMed ID: 37228404
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Fludrocortisone and Hydrocortisone vs Hydrocortisone Alone Among Patients With Septic Shock.
Bosch NA; Teja B; Law AC; Pang B; Jafarzadeh SR; Walkey AJ
JAMA Intern Med; 2023 May; 183(5):451-459. PubMed ID: 36972033
[TBL] [Abstract][Full Text] [Related]
13. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
Bauer SR; Lam SW; Cha SS; Oyen LJ
J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
[TBL] [Abstract][Full Text] [Related]
14. Abrupt Discontinuation Versus Taper of Hydrocortisone in Patients With Septic Shock.
Carabetta S; Allen B; Cannon C; Johnson T
Ann Pharmacother; 2023 Apr; 57(4):375-381. PubMed ID: 35927963
[TBL] [Abstract][Full Text] [Related]
15. The Timing of Initiating Hydrocortisone and Long-term Mortality in Septic Shock.
Zhang L; Gu WJ; Huang T; Lyu J; Yin H
Anesth Analg; 2023 Oct; 137(4):850-858. PubMed ID: 37171987
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Fludrocortisone Plus Hydrocortisone versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Teja B; Berube M; Pereira TV; Law AC; Schanock C; Pang B; Wunsch H; Walkey AJ; Bosch NA
Am J Respir Crit Care Med; 2024 May; 209(10):1219-1228. PubMed ID: 38271488
[No Abstract] [Full Text] [Related]
17. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
[TBL] [Abstract][Full Text] [Related]
18. Effect of hydrocortisone versus methylprednisolone on clinical outcomes in oncology patients with septic shock.
McDonnell E; Collins R; Hernandez M; Brown ART
J Oncol Pharm Pract; 2021 Jan; 27(1):54-62. PubMed ID: 32686618
[TBL] [Abstract][Full Text] [Related]
19. Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: A retrospective cohort study.
Bonnin S; Radosevich JJ; Lee YG; Feldman JP; Barletta JF
J Crit Care; 2021 Apr; 62():111-116. PubMed ID: 33338674
[TBL] [Abstract][Full Text] [Related]
20. Effect of Low-Dose Hydrocortisone Therapy in Adult Patients With Septic Shock: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials.
Lyu QQ; Chen QH; Zheng RQ; Yu JQ; Gu XH
J Intensive Care Med; 2020 Oct; 35(10):971-983. PubMed ID: 30270720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]